MXPA05011170A - Interferon beta en el sindrome respiratorio agudo severo. - Google Patents

Interferon beta en el sindrome respiratorio agudo severo.

Info

Publication number
MXPA05011170A
MXPA05011170A MXPA05011170A MXPA05011170A MXPA05011170A MX PA05011170 A MXPA05011170 A MX PA05011170A MX PA05011170 A MXPA05011170 A MX PA05011170A MX PA05011170 A MXPA05011170 A MX PA05011170A MX PA05011170 A MXPA05011170 A MX PA05011170A
Authority
MX
Mexico
Prior art keywords
sars
acute respiratory
respiratory syndrome
severe acute
interferon beta
Prior art date
Application number
MXPA05011170A
Other languages
English (en)
Inventor
Luca Giampiero De
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of MXPA05011170A publication Critical patent/MXPA05011170A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe en la presente invencion el uso de un interferon (IFN) para la elaboracion de un medicamento util para el tratamiento y/o prevencion del sindrome respiratorio agudo severo (SARS).
MXPA05011170A 2003-04-17 2004-04-06 Interferon beta en el sindrome respiratorio agudo severo. MXPA05011170A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03101066 2003-04-17
PCT/EP2004/050456 WO2004091653A1 (en) 2003-04-17 2004-04-06 Interferon beta in severe acute respiratory syndrome (sars)

Publications (1)

Publication Number Publication Date
MXPA05011170A true MXPA05011170A (es) 2005-12-14

Family

ID=33185950

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05011170A MXPA05011170A (es) 2003-04-17 2004-04-06 Interferon beta en el sindrome respiratorio agudo severo.

Country Status (13)

Country Link
US (1) US20070026014A1 (es)
EP (1) EP1613342A1 (es)
JP (1) JP2006523655A (es)
KR (1) KR20050112127A (es)
CN (1) CN1798572A (es)
AU (1) AU2004229185A1 (es)
BR (1) BRPI0409484A (es)
CA (1) CA2521650A1 (es)
EA (1) EA008766B1 (es)
MX (1) MXPA05011170A (es)
NO (1) NO20055243L (es)
UA (1) UA81481C2 (es)
WO (1) WO2004091653A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004110392A2 (en) * 2003-04-01 2004-12-23 Intermune, Inc. Compositions and methods for treating coronavirus infection and sars
US7482149B2 (en) * 2003-06-09 2009-01-27 Genome Institute Of Singapore Inhibition of SARS coronavirus infection with clinically approved antiviral drugs
US9295669B2 (en) 2010-12-14 2016-03-29 Hoffman La-Roche Inc. Combination therapy for proliferative disorders
CA3180390A1 (en) * 2020-03-27 2021-09-30 Fergus MANFORD Compositions for the treatment of a respiratory condition
US20220125661A1 (en) * 2020-10-22 2022-04-28 Jacob Waterman Patient-Worn Therapeutic Apparatus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
KR100694345B1 (ko) * 1998-05-15 2007-03-12 쉐링 코포레이션 리바비린 및 인터페론 알파를 포함하는, 만성 ｃ형 간염에 걸린 항-바이러스 치료에 대한 나이브 환자의 치료용 약제학적 조성물
JP2002220343A (ja) * 2001-01-26 2002-08-09 Toray Ind Inc びまん性肺疾患延命剤
WO2003031587A2 (en) * 2001-10-09 2003-04-17 The Regents Of The University Of California Use of stat-6 inhibitors as therapeutic agents
US20050137154A1 (en) * 2003-05-16 2005-06-23 Hemispherx Biopharma Treating server acute respiratory syndrome
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections

Also Published As

Publication number Publication date
EP1613342A1 (en) 2006-01-11
NO20055243L (no) 2005-11-08
US20070026014A1 (en) 2007-02-01
WO2004091653A1 (en) 2004-10-28
CA2521650A1 (en) 2004-10-28
KR20050112127A (ko) 2005-11-29
AU2004229185A1 (en) 2004-10-28
JP2006523655A (ja) 2006-10-19
EA008766B1 (ru) 2007-08-31
EA200501625A1 (ru) 2006-04-28
BRPI0409484A (pt) 2006-05-02
UA81481C2 (en) 2008-01-10
CN1798572A (zh) 2006-07-05

Similar Documents

Publication Publication Date Title
IL171972A0 (en) Compositions and methods for treatment of severe acute respiratory syndrome(sars)
HUP0301444A2 (hu) Ribavirin és pegilezett alfa-interferon alkalmazása HCV fertőzés kezelésére szolgáló gyógyszerkészítmény előállítására
SI1458360T1 (sl) Pulmonalno dajanje aminoglikozidov
AU2003220317A8 (en) Methods and drug delivery systems for the treatment of orofacial diseases
HUP0103423A2 (hu) Ribavirint és alfa-interferont tartalmazó kombinált terápia vírusellenes kezelésben nem részesült, krónikus hepatitis C fertőzött paciensek kezelésében
AU2002360517A1 (en) Respiratory infection prevention and treatment with terpene-containing compositions
IL171956A0 (en) Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis
WO2002069945A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und pde-iv-inhibitoren
HUP0002755A2 (hu) Eljárások szklerózis multiplexben szenvedő betegek kezelésére konszenzus interferonnal
TW200509961A (en) Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections
NZ594814A (en) Peptide that is derived from a milk protein and has an antioxidative effect and also acts as a blood adiponectin level increase promotion and/or decrease inhibition agent
HK1068106A1 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
EP1575582A4 (en) COMBINED THERAPY FOR THE TREATMENT OF ACUTE LEUKEMIA AND MYELODYSPLASIC SYNDROME
WO2007057436A3 (en) Interferon in influenza
PL364573A1 (en) Adenosine analogues for the treatment of the insulin resistance syndrome and diabetes
MXPA05011170A (es) Interferon beta en el sindrome respiratorio agudo severo.
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
HK1062810A1 (en) Use of il-18 inhibitors for the manufacture of medicaments for treatment and/or prevention of heartdisease
WO2002069979A3 (en) Pharmaceutical formulation comprising r-salmeterol and fluticasone propionate
DE69918961D1 (de) Verbesserte inhalationspräparate
WO2005123113A3 (en) Interferon compositions and methods of use thereof
PL369296A1 (en) Use of gp130 activators in diabetic neuropathy
WO2001028535A3 (en) Pharmaceutical formulations comprising a combination of s-salmeterol and fluticasone propionate
WO2004094991A3 (en) Treatment or prevention of respiratory viral infections with alpha thymosin peptides
WO2006091222A3 (en) Methods of treating and preventing severe acute respiratory syndrome (sars) with avr118

Legal Events

Date Code Title Description
FA Abandonment or withdrawal